TL;DR
Two directors offload holdings at $15.81 per share as stock trades significantly higher.
June 25, 2025
Two directors of Slide Insurance Holdings, Inc. (NYSE:SLDE) executed significant stock sales totaling $5.78 million on June 20, 2025, according to Form 4 filings with the Securities and Exchange Commission.
Transaction Details
Director Robert Gries Jr. sold 358,457 shares through GRM Family Limited Partnership, an entity he controls, generating $5.67 million in proceeds.
The shares were sold at $15.81 each, the same price used in a smaller transaction by fellow director Stephen L. Rohde, who sold 7,083 shares for $111,982.
Both sales occurred pursuant to underwriting agreements related to Slide Insurance Holdings’ initial public offering, suggesting the transactions were part of the company’s IPO process rather than discretionary market sales.
Stock Performance Impact
The timing of these sales has proven advantageous for the buyers, as SLDE shares are currently trading at $21.74, representing a 37% premium to the directors’ sale price.
This significant appreciation has occurred in just five days since the transactions.
Following his sale, Rohde directly owns 20,417 shares of Slide Insurance Holdings. Meanwhile, GRM Family Limited Partnership, controlled by Gries, retains 2,031,265 shares after the transaction.
On the same day as the stock sale, the partnership also converted 2,389,722 shares of Series A Preferred Stock into common stock.
IPO Background
Slide Insurance Holdings made a notable public market debut, with shares opening at $21 on the Nasdaq Global Select Market, surpassing the IPO price of $17.
The company completed an upsized offering of 24 million shares, with Slide itself selling 16.67 million shares while stockholders offered 7.33 million shares.
The IPO structure included a 30-day greenshoe option allowing underwriters to purchase an additional 3.6 million shares at the offering price. Barclays and Morgan Stanley served as joint book-running managers for the offering.
Market Outlook
SLDE maintains a great financial health score, supported by strong profitability metrics, though the stock appears overvalued at current levels given its rapid post-IPO appreciation.
The substantial insider sales, while part of the IPO process, represent significant liquidity events for the directors as Slide Insurance Holdings establishes itself as a publicly traded company in the competitive insurance sector.